| Literature DB >> 28581379 |
Dorcus Kiwanuka Henriksson1,2, Mio Fredriksson3, Peter Waiswa2,4, Katarina Selling1, Stefan Swartling Peterson1,4.
Abstract
BACKGROUND: Poor quality of care and access to effective and affordable interventions have been attributed to constraints and bottlenecks within and outside the health system. However, there is limited understanding of health system barriers to utilization and delivery of appropriate, high-impact, and cost-effective interventions at the point of service delivery in districts and sub-districts in low-income countries. In this study we illustrate the use of the bottleneck analysis approach, which could be used to identify bottlenecks in service delivery within the district health system.Entities:
Keywords: Tanahashi model; bottleneck analysis; demand-side determinants; district health systems; maternal and newborn care; supply-side determinants
Mesh:
Year: 2017 PMID: 28581379 PMCID: PMC5496050 DOI: 10.1080/16549716.2017.1327256
Source DB: PubMed Journal: Glob Health Action ISSN: 1654-9880 Impact factor: 2.640
Figure 1.Modified Tanahashi model applied to analyze bottlenecks.
Definition of coverage determinants used in the Tanahashi model.
| Coverage determinants | Definition |
|---|---|
| Availability of essential health commodities | Refers to availability of health system inputs, for example, medicines and related commodities for maternal and newborn care. |
| Availability of human resources | Represents availability of staff at health facilities that provide maternal and newborn care services. |
| Accessibility | Physical accessibility of service delivery points. |
| Initial utilization | Refers to first contact or use of health services or interventions, for example, first antenatal visit. |
| Continuous coverage | Refers to the extent to which the full course of contact with the health system required to be effective was achieved, for example, the proportion of women receiving four antenatal contacts. |
| Effective coverage | Represents the quality of the intervention which is defined as the minimum inputs and processes sufficient to achieve defined health effects. |
Data sources used for the study.
| Public health facilities | |||||
|---|---|---|---|---|---|
| District | Number of women interviewed | HC II | HC III | HC IV | Total |
| Mayuge | 3372 | 24 | 4 | 2 | 30 |
| Namayingo | 3141 | 16 | 3 | 1 | 20 |
| Total | 6513 | 40 | 7 | 3 | 50 |
Coverage measures used for each of the modified Tanahashi model determinants and assumptions made.
| Interventions | ||||
|---|---|---|---|---|
| Determinants | Use of iron and folic acid to prevent anemia during pregnancy | Intermittent presumptive treatment for malaria | HIV counseling and testing | Syphilis test |
| Accessibility | Average straight line distance from the woman’s household to the nearest public health facility.2 | Average straight line distance from the woman’s household to the nearest public health facility.2 | Average straight line distance from the woman’s household to the nearest public health facility.2 | Average straight line distance from the woman’s household to the nearest public health facility.2 |
| Availability of human resources | Average proportion of staff employed at the facility on the day of the survey as compared to the Uganda national staffing guidelines.1 | Average proportion of staff employed at the facility on the day of the survey as compared to the Uganda national staffing guidelines.1 | Average proportion of staff employed at the facility on the day of the survey as compared to the Uganda national staffing guidelines.1 | Average proportion of staff employed at the facility on the day of the survey as compared to the Uganda national staffing guidelines.1 |
| Availability of essential health commodities | Proportion of times both ferrous sulphate and folic acid or combined ferrous/folate were in stock at the health facility on the day of the facility census. | Proportion of times Sulphadoxine Pyrimethamine was in stock at the health facility on the day of the facility census. | Proportion of health facilities that provide HIV diagnostic services that had HIV test kits in stock on the day of the survey. | Proportion of health facilities that provide syphilis diagnostic services that had syphilis rapid test kits in stock on the day of the survey. |
| Initial utilization | Proportion who took tablets or syrup for 30 or less days. | Proportion of women who attended ANC clinic during the pregnancy. | Proportion of women who got information related to HIV/AIDS and on being tested for the HIV virus. | Proportion of women who attended ANC clinic during the pregnancy. |
| Continuous utilization | Proportion who took tablets or syrup for 31–89 days. | Proportion of women who received one dose of malaria prevention medicine. | Proportion of women who gave blood for any test during pregnancy. | Proportion of women who gave blood for testing during the pregnancy. |
| Effective coverage | Proportion who took tablets or syrup for 90 days. | Proportion of women who received at least two doses of malaria prevention medicine. | Proportion of women who gave blood for testing during the pregnancy, who received HIV test results. | Proportion of women who gave blood for testing during the pregnancy, who received syphilis test results. |
Figure 2.Use of iron and folic acid during pregnancy.
Figure 4.HIV counseling and testing and syphilis testing during pregnancy.
Figure 3.Intermittent presumptive treatment of malaria.